Comparison Between RCT in Single and Two Visits, With and Without Intracanal Dressing, in Apical Repair
Launched by NEW YORK UNIVERSITY · Feb 15, 2022
Trial Information
Current as of June 12, 2025
Unknown status
Keywords
ClinConnect Summary
All patients will voluntarily seek endodontic treatment in the Brazilian Unified Health System in the cities of Itabuna, in the State of Bahia, in Goiânia, in the State of Goiás, Brazil. After an assessment of eligibility and informed consent, patients will be randomly assigned to one of 3 clinical study groups. Patients who agree to participate in this study will sign an informed consent form. Sample Size: The determination of the sample size will be performed sequentially, with a minimum of 210 statistical units (teeth) to be recruited in the first stage, and the second stage of recruitme...
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Patients diagnosed with apical periodontitis in lower molar teeth (first or second molars), the periradicular lesion with a diameter between 1 and 5mm analyzed through the real 1:1 tomographic scale
- • Asymptomatic patients
- • Patients who spontaneously agree and sign the informed consent form
- • Patients in good health
- • Patients who are not taking antibiotics and anti-inflammatory drugs
- Exclusion criteria:
- • Patients with systemic diseases (diabetes, transplants, heart disease, liver failure and kidney failure)
- • Immunodepressed patients
- • Teeth with extensive coronary destruction that makes direct restoration with composite resin unfeasible
- • Calcified teeth
- • Teeth with incomplete root formation
- • Teeth with persistent exudation
- • Teeth with anatomical complexities that prevent endodontic treatment in a single visit
- • Teeth recommended for endodontic retreatment
- • Teeth with advanced periodontal pocket
- • Teeth in which foraminal patency is not obtained
About New York University
New York University (NYU) is a prestigious research institution renowned for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure and a diverse team of leading experts, NYU conducts cutting-edge research across various therapeutic areas, focusing on translating scientific discoveries into effective treatments. The university fosters collaboration among multidisciplinary teams and engages with a broad patient population, ensuring that its trials adhere to the highest ethical standards and regulatory requirements. NYU's dedication to excellence in research and education positions it as a key contributor to the advancement of healthcare and clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Itabuna, Bahia, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials